638 related articles for article (PubMed ID: 30576008)
1. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
4. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
5. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
[TBL] [Abstract][Full Text] [Related]
6. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
8. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
9. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
11. Manual MRI morphometry in Parkinsonian syndromes.
Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
[TBL] [Abstract][Full Text] [Related]
12. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders.
Nilsson J; Constantinescu J; Nellgård B; Jakobsson P; Brum WS; Gobom J; Forsgren L; Dalla K; Constantinescu R; Zetterberg H; Hansson O; Blennow K; Bäckström D; Brinkmalm A
Mov Disord; 2023 Feb; 38(2):267-277. PubMed ID: 36504237
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.
Yoon WT
Neurol Neurochir Pol; 2018; 52(1):48-53. PubMed ID: 29196058
[TBL] [Abstract][Full Text] [Related]
17. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
18. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
19. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
20. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
Engen PA; Dodiya HB; Naqib A; Forsyth CB; Green SJ; Voigt RM; Kordower JH; Mutlu EA; Shannon KM; Keshavarzian A
J Parkinsons Dis; 2017; 7(2):331-346. PubMed ID: 28234259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
